Stroke recurrence in patients with brain embolism and patent foramen ovale - Association with deep vein thrombosis detedted by ultrasonography

Clinical Neurology

Volumn 44, Issue 1, 2004, Pages 7-13

  Nagano, Keiko ^a   Otsubo, Ryoichi ^a   Yasaka, Masahiro ^a   Kajimoto, Katsufumi ^a   Oe, Hiroshi ^a   Nagatsuka, Kazuyuki ^a   Naritomi, Hiroaki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Deep vein thrombosis; Paradoxical embolism; Patent foramen ovale; R L shunt; Venous ultrasonography

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN III; ANTITHROMBOCYTIC AGENT; D DIMER; THROMBIN ANTITHROMBIN COMPLEX; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; AORTA ARCH; ARTICLE; BRAIN EMBOLISM; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; ECHOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; MALE; PARADOXICAL EMBOLISM; PHLEBOGRAPHY; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGED; ANTICOAGULANTS; CEREBROVASCULAR ACCIDENT; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; INTRACRANIAL EMBOLISM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; VENOUS THROMBOSIS; WARFARIN;

EID: 3042724980     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lechat PH, Mas JL, Lascault G, et al: Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318: 1148-1152
2. Bevan H, Sharma K, Bradley W: Stroke in young adults. Stroke 1990; 21: 382-386
3. Biller J, Johnson MR, Adams HP Jr, et al: Further observations on cerebral or retinal ischemia in patients with right-left intracardiac shunts. Arch Neurol 1987; 44: 740-743
4. Gautier JC, Dürr A, Koussa S, et al: Paradoxical cerebral embolism with a patent foramen ovale. Cerebrovasc Dis 1991; 1: 193-202
5. Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life; an autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59: 17-20
6. Ranoux D, Cohen A, Cabanes L, et al: Patent foramen ovale: Is stroke due to paradoxical embolism? Stroke 1993; 24: 31-34
7. Bogousslavsky J, Garazi S, Jeanrenaud X, et al: Stroke recurrence in patients with patent foramen ovale: The Lausanne study. Neurology 1996; 46: 1301-1305
8. Lethen H, Flachskampf FA, Schneider R, et al: Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 1997; 80: 1066-1069
9. Stöllerger C, Slany J, Schuster I, et al: The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med 1993; 119: 461-465
10. Labropoulos N, Webb KM, Kang SS, et al: Patterns and distribution of isolated calf deep vein thrombosis. J Vasc Surg 1999; 30: 787-793
11. Hirsh J, Hoak J: Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Circulation 1996; 93: 2212-2245
12. Kraaijenhagen RA, Piovella F, Bernardi E, et al: Simplification of the diagnostic management of suspected deep vein thrombosis. Arch Intern Med 2002; 162: 907-911
13. Nendaz M, Sarasin FP, Bogousslavsky J: How to prevent stroke recurrence in patients with patent foramen ovale: Anticoagulants, antiaggregants, foramen closure, or nothing? Eur Neurol 1997; 37: 199-204
14. Hanna JP, Sun JP, Furlan AJ, et al: Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention. Stroke 1994; 25: 782-786
15. Orgera MA, O'Malley PG, Taylar AJ: Secondary prevention of cerebral ischemia in patent foramen ovale: systematic review and meta-analysis. South Med J 2001; 94: 699-703
16. Homma S, Sacco RL, Di Tullio MR, et al: Effect of medical treatment in stroke patients with patent foramen ovale. Patent foramen ovale in cryptogenic stroke study. Circulation 2002; 105: 2625-2631
17. Mas JL, Arquizan C, Lamy C, et al: Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345: 1740-1746
18. Bridges ND, Hellenbrand W, Latson L, et al: Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992; 86: 1902-1908
19. Sievert H, Babic UU, Hausdorf G, et al: Transcatheter closure of atrial septal defect and patent foramen ovale with the ASDOS device (a multi-institutional European trial). Am J Cardiol 1998; 82: 1405-1413
20. Windecker S, Wahl A, Chatterjee T, et al: Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000; 101: 893-898
21. Devuyst G, Bogousslavsky J, Ruchat P, et al: Prognosis after stroke followed by surgical closure of patent foramen ovale; A prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology 1996; 47: 1162-1166
22. Homma S, Di Tullio MR, Sacco RL, et al: Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997; 28: 2376-2381
23. Dearani JA, Ugurlu BS, Danielson GK, et al: Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999; 100: II-171-II-175
24. Hung J, Landzberg MJ, Jenkins KJ, et al: Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000; 35: 1311-1316